31 results on '"Marrari A"'
Search Results
2. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction
3. Second update of the International Registry of HLA Epitopes. I. The HLA-ABC Epitope Database
4. Trends and variability in extended ocean color time series in the main reproductive area of the Argentine hake, Merluccius hubbsi (Southwestern Atlantic Ocean)
5. O16 Toward a combined DR+DQ HLA molecular mismatch score for risk stratification of pediatric heart transplant patients
6. (40) Chronic Lung Allograft Dysfunction is Associated with an Increased Number of Autoantibodies
7. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes
8. Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings
9. HLA Eplet Mismatch Analysis of a Large Multi-Center Pediatric Heart Transplant Cohort: Not All Transplants are Immunologically Equal
10. The radiologist empowerment through virtual multidisciplinary tumor boards: The commitment of oncologic care during COVID-19 pandemic
11. Association between MRSA Colonization and Chronic Lung Allograft Dysfunction in Lung Transplantation for Cystic Fibrosis
12. OR28 Are all donor-specific hla antibodies equally associated with increased risk of chronic lung allograft dysfunction?
13. Increased Hazard of Chronic Lung Allograft Dysfunction in the Presence of Persistent and Complement Fixing Donor-Specific Antibodies
14. (482) - Treatment of Antibody Mediated Rejection of the Lung Allograft with Carfilzomib-Based Therapy
15. (303) - A Three Center Study Reveals New Insights into the Impact of Non-HLA Antibodies on the Acute Rejection Process in Lung Transplantation
16. (305) - New Insights in to the Impact of Auto-Antibodies on the Acute Rejection Process in Lung Transplantation
17. Vaccination with Survivin and PSMA-derived Peptides: A Pilot Study in Prostate Cancer Patients Failing Radiotherapy or Surgery
18. Interlaboratory comparisons of serum screening for HLA antibody determination and crossmatching by ELISA and Flow cytometry methods
19. Hlamatchmaker based serum analysis for identifying acceptable and unacceptable HLA antigen mismatches for highly sensitized patients
20. Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis
21. Alloreactive T-cell recognition of two DQβ allelic specificities associated with DQw1
22. Progress report on the ASHI/CAP proficiency survey program in histocompatibility testing II. HLA-DR, DQ serologic typing, antibody identification, and B-cell crossmatching
23. Progress report on the ASHI/CAP proficiency survey program in histocompatibility testing I. HLA-A, B, C typing, antibody screening, and lymphocytotoxicity crossmatching
24. P754 - Progress report of the ASHI/CAP DL survey for class II HLA typing by DNA methods
25. P709 - HLA class II antibodies in highly sensitized patients awaiting renal transplantation
26. Determination of the relative immunogenicity of HLA class I epitopes: potential relevance to HLA mismatching strategies in renal transplantation
27. O219 - Development of HLA-human monoclonal antibodies
28. BC1, a new HLA-D region determinant detected by serological and cellular assays
29. Bone marrow transplantation of a patient with aplastic anemia from a HLA-identical unrelated donor
30. HLA-DR, MB and MT are three serological distinct systems of B cell alloantigens
31. Association of MB compatibility with successful kidney transplantation from related donors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.